The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A cost-effectiveness analysis of pretreatment DPYD and UGT1A1 screening in patients with metastatic colorectal cancer (mCRC) treated with FOLFIRI+bevacizumab (FOLFIRI+Bev).
 
Zachary Rivers
Stock and Other Ownership Interests - Adaptimmune; Adaptimmune; Adaptimmune; Adaptimmune; Aurinia Pharmaceuticals; Aurinia Pharmaceuticals; Aurinia Pharmaceuticals; Aurinia Pharmaceuticals; Rigel; Rigel; Rigel; Rigel; Syndax; Syndax; Syndax; Syndax
 
David D. Stenehjem
Stock and Other Ownership Interests - Salarius Pharmaceuticals; Salarius Pharmaceuticals; Salarius Pharmaceuticals; Salarius Pharmaceuticals
Consulting or Advisory Role - Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Dracen; Dracen; Dracen; Dracen; Iterion Therapeutics; Iterion Therapeutics; Iterion Therapeutics; Iterion Therapeutics; Salarius Pharmaceuticals; Salarius Pharmaceuticals; Salarius Pharmaceuticals; Salarius Pharmaceuticals
Research Funding - AstraZeneca (Inst); AstraZeneca (Inst); AstraZeneca (Inst); AstraZeneca (Inst); Bioverativ (Inst); Bioverativ (Inst); Bioverativ (Inst); Bioverativ (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Novartis (Inst); Novartis (Inst); Novartis (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb
 
Pamala Jacobson
Consulting or Advisory Role - United Health Group; United Health Group; United Health Group; United Health Group
 
Emil Lou
Honoraria - Boston Scientific; Boston Scientific; Boston Scientific; Boston Scientific; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; Novocure; Novocure; Novocure; Novocure
Consulting or Advisory Role - Boston Scientific; Boston Scientific; Boston Scientific; Boston Scientific; Minnetronix Medical; Minnetronix Medical; Minnetronix Medical; Minnetronix Medical; NomoCan; NomoCan; NomoCan; NomoCan; Novocure; Novocure; Novocure; Novocure; Novocure; Novocure; Novocure; Novocure; Novocure; Novocure; Novocure; Novocure; Novocure; Novocure; Novocure; Novocure
Research Funding - Novocure; Novocure; Novocure; Novocure
Travel, Accommodations, Expenses - GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline
 
Andrew Nelson
No Relationships to Disclose
 
Karen M Kuntz
Employment - Medtronic (I); Medtronic (I); Medtronic (I); Medtronic (I)
Stock and Other Ownership Interests - Medtronic (I); Medtronic (I); Medtronic (I); Medtronic (I)